NCT00241215View on ClinicalTrials.gov

Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

November 30, 2005

Conditions
Cervicobrachial NeuralgiaMyofascial Pain Syndromes
Interventions
DRUG

Botulinum toxin serotype A

Trial Locations (1)

90404

UCLA Pain Management Center, Santa Monica

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT00241215 - Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome | Biotech Hunter | Biotech Hunter